FDA.reportPublic FDA data

HyperRAB 900 UNT in 3 mL Injection

RxCUI
2267418
RxNorm name
HyperRAB 900 UNT in 3 mL Injection
Display name
HyperRAB 900 UNT in 3 mL Injection
Full name
HyperRAB 900 UNT in 3 mL Injection
Term type
PSN
Status
DailyMed mapping
Updated
2026-06-04 23:39:28

Purple Book Biologic Products#

BLA, Proprietary name, Proper name table
BLAProprietary nameProper nameLicense typeStatusLatest source
101144Bayrab, HyperrabRabies Immune Globulin (Human)351(a)Rx2026-09-01

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 1 matching rows.

Set ID, RxNorm mappings, Terms table
Set IDRxNorm mappingsTermsSPL versionLabelEffective
f82880b8-998c-4659-8f20-6dcc81f258e9HyperRAB 900 UNT in 3 mL Injection [PSN] · 3 ML rabies immune globulin, human 300 UNT/ML Injection [HyperRAB] [SBD] · 3 ML HyperRAB 300 UNT/ML Injection [SY] · HyperRAB 900 UNT per 3 ML Injection [SY]410These highlights do not include all the information needed to use HYPERRAB safely and effectively. See full prescribing information for HYPERRAB. HYPERRAB [rabies immune globulin (human)] solution for infiltration and intramuscular injection Initial U.S. Approval: 197420240920